Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Evaluating the Prevalence and Severity of MASLD in Primary Care - a Follow-up Study
Authors not listed
Linkoeping University · 2025
Abstract
The goal of this observational study is to understand how metabolic dysfunction-associated steatotic liver disease (MASLD) changes over time in individuals with type 2 diabetes who previously participated in the EPSONIP study.
The main questions it aims to answer are:
1. How common are MASLD and advanced liver fibrosis at long-term follow-up?
2. Which factors are associated with progression or regression of liver fat accumulation and liver fibrosis over time?
Participants will:
* Undergo a clinical examination and review of medical history.
* Provide blood, urine, and biobank samples.
* Undergo liver assessment using vibration-controlled transient elastography (VCTE).
* Undergo magnetic resonance imaging (MRI) to assess liver fat, liver fibrosis, and body composition.
* Complete questionnaires regarding lifestyle and physical activity.
* Undergo physical activity measurements using accelerometers and additional assessments related to blood pressure and sleep apnea.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-27 MST
Cite this
APA
Anonymous. (2025). Evaluating the Prevalence and Severity of MASLD in Primary Care - a Follow-up Study. <em>Linkoeping University</em>. https://clinicaltrials.gov/study/NCT07312136
Vancouver
Anonymous. Evaluating the Prevalence and Severity of MASLD in Primary Care - a Follow-up Study. Linkoeping University. 2025.
BibTeX
@misc{anon2025Evalua,
title = {Evaluating the Prevalence and Severity of MASLD in Primary Care - a Follow-up Study},
author = {Anonymous},
journal = {Linkoeping University},
year = {2025},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
General University Hospital, Prague 2023
Open access · US-GOV
Bone Marrow Adipose Tissue as a New Parameter in Relation to Bone and Energy Metabolism in Obesity and Type 2 Diabetes Mellitus
Hepatology communications 2026
Open access · OA
Hepatocyte senescence in metabolic dysfunction–associated steatotic liver disease (MASLD)
University of Pavia 2024
Open access · US-GOV
Impatto Dell'Ambiente Urbano Sull'età Biologica: Effetto Della qualità Dell'Aria e Dello Stress Lavorativo a Pavia su Citochine Infiammatorie e Profilo di Metilazione Del DNA
Université du Québec à Trois-Rivières 2025
Open access · US-GOV
Exploration of Factors Influencing Chiropractors' Therapeutic Choices in the Management of Aging Patients: an Observational Study
Cardiovascular Diabetology 2023
Open access · CC-BY
Maternal obesity and gestational diabetes reprogram the methylome of offspring beyond birth by inducing epigenetic signatures in metabolic and developmental pathways
Cell Communication and Signaling 2025
Open access · CC-BY